Eledon Pharmaceuticals (ELDN) Other Gross PP&E Adjustments (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Other Gross PP&E Adjustments of -$786000.0 for Q1 2026, up 18.3% year-on-year from -$664439.4 in Q1 2025, and up 29.06% on a QoQ basis from -$1.1 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Other Gross PP&E Adjustments data on file, last reported at -$786000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 18.3% year-over-year to -$786000.0; the trailing twelve-month figure through Mar 2026 stood at -$786000.0 (up 18.3% YoY), and the FY2025 full-year result was -$1.1 million, up 73.66% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$786000.0, up from -$1.1 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$402000.0 in Q1 2024 and bottomed at -$4.2 million in Q4 2024.
- The 5-year median for Other Gross PP&E Adjustments is -$934000.0 (2022), against an average of -$1.4 million.
- The widest annual swing landed in 2022, when Other Gross PP&E Adjustments sank 240.88%; it then jumped 73.66% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$3.6 million in 2022, then advanced by 4.51% to -$3.4 million in 2023, then fell by 21.94% to -$4.2 million in 2024, then surged by 73.66% to -$1.1 million in 2025, then climbed by 29.06% to -$786000.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$786000.0 (Q1 2026), -$1.1 million (Q4 2025), and -$1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -786,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -786,000.00 |
| Mar 31, 2026 | -786,000.00 |
| Dec 31, 2025 | -1.11 Mn |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Sep 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.32 Mn |
| Jun 30, 2025 | -1.32 Mn |
| Mar 31, 2025 | -962,000.00 |
| Mar 31, 2025 | -962,000.00 |
| Dec 31, 2024 | -4.21 Mn |
| Dec 31, 2024 | -4.21 Mn |
| Sep 30, 2024 | -946,000.00 |
| Sep 30, 2024 | -946,000.00 |
| Jun 30, 2024 | -715,000.00 |
| Jun 30, 2024 | -715,000.00 |
| Mar 31, 2024 | -402,000.00 |
| Mar 31, 2024 | -402,000.00 |
| Dec 31, 2023 | -3.45 Mn |
| Dec 31, 2023 | -3.45 Mn |
| Sep 30, 2023 | -520,000.00 |
| Sep 30, 2023 | -520,000.00 |
| Jun 30, 2023 | -586,000.00 |
| Jun 30, 2023 | -586,000.00 |
| Mar 31, 2023 | -853,000.00 |
| Mar 31, 2023 | -853,000.00 |
| Dec 31, 2022 | -3.61 Mn |
| Dec 31, 2022 | -3.61 Mn |
| Sep 30, 2022 | -934,000.00 |
| Sep 30, 2022 | -934,000.00 |
| Jun 30, 2022 | -706,000.00 |
| Jun 30, 2022 | -706,000.00 |
| Mar 31, 2022 | -804,000.00 |
| Mar 31, 2022 | -804,000.00 |
| Dec 31, 2021 | -2.64 Mn |
| Dec 31, 2021 | -2.64 Mn |
| Sep 30, 2021 | -274,000.00 |
| Sep 30, 2021 | -274,000.00 |
| Jun 30, 2021 | -385,000.00 |
| Jun 30, 2021 | -385,000.00 |
| Mar 31, 2021 | -251,000.00 |
| Mar 31, 2021 | -251,000.00 |
| Dec 31, 2020 | -940,000.00 |
| Dec 31, 2020 | -940,000.00 |
| Sep 30, 2020 | -703,000.00 |
| Sep 30, 2020 | -703,000.00 |
| Jun 30, 2020 | -333,000.00 |
| Jun 30, 2020 | -333,000.00 |
| Mar 31, 2020 | -392,000.00 |
| Mar 31, 2020 | -392,000.00 |
| Dec 31, 2019 | -707,000.00 |
| Dec 31, 2019 | -707,000.00 |
| Sep 30, 2019 | -569,000.00 |
| Sep 30, 2019 | -569,000.00 |
| Jun 30, 2019 | -552,000.00 |
| Jun 30, 2019 | -552,000.00 |
| Mar 31, 2019 | -707,000.00 |
| Mar 31, 2019 | -707,000.00 |
| Dec 31, 2018 | -301,000.00 |
| Dec 31, 2018 | -301,000.00 |
| Sep 30, 2018 | -182,000.00 |
| Sep 30, 2018 | -182,000.00 |
| Jun 30, 2018 | -171,000.00 |
| Jun 30, 2018 | -171,000.00 |
| Mar 31, 2018 | -372,000.00 |
| Mar 31, 2018 | -372,000.00 |
| Dec 31, 2017 | -158,000.00 |
| Dec 31, 2017 | -158,000.00 |
| Sep 30, 2017 | -276,000.00 |
| Sep 30, 2017 | -276,000.00 |
| Mar 31, 2017 | -1.11 Mn |
| Mar 31, 2017 | -1.11 Mn |
| Dec 31, 2016 | -643,000.00 |
| Dec 31, 2016 | -643,000.00 |
| Sep 30, 2016 | -734,000.00 |
| Sep 30, 2016 | -734,000.00 |
| Jun 30, 2016 | -468,000.00 |
| Jun 30, 2016 | -468,000.00 |
| Mar 31, 2016 | -614,000.00 |
| Mar 31, 2016 | -614,000.00 |
| Dec 31, 2015 | -717,000.00 |
| Dec 31, 2015 | -717,000.00 |
| Sep 30, 2015 | -597,000.00 |
| Sep 30, 2015 | -597,000.00 |
| Jun 30, 2015 | -572,000.00 |
| Jun 30, 2015 | -572,000.00 |
| Mar 31, 2015 | -397,000.00 |
| Mar 31, 2015 | -397,000.00 |
| Dec 31, 2014 | -521,000.00 |
| Dec 31, 2014 | -521,000.00 |
| Sep 30, 2014 | -710,000.00 |
| Sep 30, 2014 | -710,000.00 |
| Dec 31, 2013 | -266,000.00 |
| Dec 31, 2013 | -266,000.00 |